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Disparities of Cancer Incidence in Michigan’s
American Indians
Spotlight on Breast Cancer
Emily L. Roen, MPH1; Glenn E. Copeland, MBA2; Noel L. Pinagtore, BS, CPH3; Rafael Meza, PhD1;
and Amr S. Soliman, MD, PhD4
BACKGROUND: In American Indians (AIs), cancer is a leading cause of mortality, yet their disease burden is not fully understood due
to unaddressed racial misclassification in cancer registries. This study describes cancer trends among AIs in Michigan, focusing on
breast cancer, in a linked data set of Indian Health Service (IHS), tribal, and state cancer registry data adjusted for misclassification.
METHODS: AI status was based on reported race and linkage to IHS data and tribal registries. Data with complete linkage on all inci-
dent cancer cases in Michigan from 1995 to 2004 was used to calculate age-standardized incidence estimates for invasive all-site and
female breast cancers stratified by racial group. For female breast cancers, stage- and age-specific incidence and percent distribu-
tions of early- versus late-stage cancers and age of diagnosis were calculated. RESULTS: More than 50% of all AI cases were identi-
fied through IHS and/or tribal linkage. In the linked data, AIs had the lowest rates of all-sites and breast cancer. For breast cancers, AI
women had a greater late-stage cancer burden and a younger mean age of diagnosis as compared to whites. Although the age-
specific rate for whites was greater than for AI women in nearly all age groups, the difference in hazard ratio increased with increas-
ing age. CONCLUSIONS: Our state-specific information will help formulate effective, tailored cancer prevention strategies to this pop-
ulation in Michigan. The data linkages used in our study are crucial for generating accurate rates and can be effective in addressing
misclassification of the AI population and formulating cancer prevention strategies for AI nationwide. Cancer 2014;120:1847–53.
VC 2014 American Cancer Society.
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INTRODUCTION
According to the US Centers for Disease Control and Prevention (CDC), cancer is a leading cause of death within the
American Indian/Alaskan Native (AI/AN) population1 and data from the Surveillance, Epidemiology, and End Results
(SEER) registries of the National Cancer Institute show little progress in lowering the cancer burden of the AI population
compared to other racial groups.2,3 For women nationwide and in Michigan specifically, breast cancer is of concern as the
leading cause of cancer and second-leading cause of cancer-related death.2,3 In 2008 inMichigan, 6711 women were diag-
nosed with an invasive breast cancer, and in 2009, 1406 died from breast cancer.4,5 Little is known, however, of the breast
cancer burden specifically for AI women in Michigan. National data shows that whereas breast cancer mortality rates have
been decreasing for all races, AI women have seen no change.2,6,7 In addition, a higher percentage of breast cancers diag-
nosed among AI/AN women are at a later stage and earlier age of diagnosis than non-Hispanic white (NHW) women.6
The mean age of diagnosis for AI/AN was 57.5 years as compared to 63.4 years for NHWwomen.8
Racial or ethnic minority individuals are underrepresented in cancer registries mainly due to racial misclassification,
resulting from incorrect or missing racial information on medical forms. For AI/AN individuals, this misclassification is
particularly high.9-16 To improve accurate classification, data linkage is a technique that matches multiple records from
different sources that identify the same person. For identification of AI/AN individuals, the Indian Health Service (IHS)
and CDC have arranged for annual linkage of state cancer registries to IHS participant files to address AI misclassification.
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Some states also link their registries to tribal enrollment
records. These techniques have been very effective, and
many cancer registries nationwide now use them as a
standard tool for improving racial data.13
By working with the Michigan Intertribal Council
and individual tribes, the Michigan registry has developed
an understanding with the tribes that has permitted tribal
linkages for use by tribal health planners in assessing and
addressing cancer prevention and control issues for their
tribe with a side benefit of improving the completeness of
AI ascertainment within the state registry. Tribe-specific
cancer incidence data will be shared with a tribe for their
analysis while protecting the identity of individual cancer
patients. The state can use the results to improve the accu-
racy of AI classification within the statewide registry, and
data specific to an individual tribe will not be released
without tribal knowledge and consent. At present, 5 tribal
rolls have been linked, which represents more than 80%
of theMichigan tribal population, according to Intertribal
Council records.
As the number of individuals identified as AI/AN
increases after linkage, the cancer incidence estimates are
expected to increase for that population as well,13-16
which was previously demonstrated after conducting a
linkage with one tribe in Michigan. Linkage with IHS
records from 1995 to 2004 revealed 643 racially misclassi-
fied cancer cases, with an additional 190 misclassified
cases found through tribal linkage. These corresponded to
a 97% and 15% increase in number of AI cases, respec-
tively. After both linkages, the all-sites age-adjusted inci-
dence rate estimates increased dramatically.13 These
findings support the importance of using both IHS and
tribal records for linkage despite previous evidence sug-
gesting little added benefit of using tribal links.17 Simi-
larly, dramatic increases in individuals identified and
cancer rates were observed in 2 linkage studies conducted
inWisconsin andMinnesota.14,15
There are 12 federally recognized tribes in Michigan
and a total AI population of 82,565 (0.8% of the total
Michigan population) in 2010.18,19 The number of AI
individuals has been increasing by approximately 44%
over the past 20 years and is experiencing the same demo-
graphic shift as the rest of the United States with an
increasing presence of middle-aged and older populations.
Between 1990 and 2010, the AI population aged 65 years
and older increased by more than 100%.19
Because of the previous underreporting of AI cancer
cases and the current demographic shift, the cancer bur-
den in the AI population is only partially understood, but
is likely much larger than currently estimated, indicating
the need for more targeted cancer prevention and control
programs. Now that the quality of racial data has
improved, the objective of this study was to investigate the
all-sites and breast cancer trends that affect Michigan’s AI
population as compared to other racial groups. This will
provide new insights into the corrected incidence esti-
mates allowing for future epidemiologic and cancer pre-
vention studies in this population.
MATERIALS AND METHODS
Data on all incident cancer cases in Michigan from 1985
to 2009 was obtained from the Michigan Department of
Community Health (MDCH). The variables used for
analysis included self-reported race, an IHS link variable,
a tribal link variable, year of diagnosis, primary cancer site
code, tumor behavior, summary stage, sex, and age at di-
agnosis. IHS linkage for all cancer cases in Michigan is
conducted annually in coordination with the CDC Divi-
sion of Epidemiology in Albuquerque, NM, assigned to
the IHS. Tribal linkages using tribal enrollment records
are done sporadically at the convenience and with the per-
mission and cooperation of individual tribes.13 For this
analysis, a case’s racial identity was determined based on
the reported race, IHS, and tribal linkage variables. A case
that had any mention of AI as a reported race, a positive
IHS link, or a positive tribal link was classified as AI.
Cases of white or black race were also classified as such
based on reported race and the absence of a positive IHS
or tribal link.
Incidence estimates were calculated for all-sites and
female breast cancers stratified by sex, race (all races,
white, black, AI), and year of diagnosis. Rate calculations
were restricted to the years 1995-2004. This restriction
was necessary to address the combined effects of tribal
enrollment file completeness and the cancer diagnosis
years linked to all 5 participating tribes. At the time of the
study, 5 tribes had completed one tribal linkage con-
ducted between 2006 and 2012. Matching over these 6
years resulted in tribal enrollment being matched against
varying cancer incidence time periods from through 2004
to through 2009. The years selected restrict the analysis to
diagnosis years for which all 5 tribal linkages are
complete.
For the all-sites and breast cancer incidence rates,
only invasive cancers (behavior code of 3 and all bladder
cancers) were included, and only females were included
for breast cancer calculations. Stage-specific breast cancer
rates were also calculated for those ages 50 years and older.
Early-stage was defined as all in situ and localized cancers,
whereas late-stage included all regional and distant
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cancers. The 95% confidence intervals (CIs) were gener-
ated using a binominal approximation.20 All rates used
the corresponding population from census data as the de-
nominator, were age-standardized to the United States
standard population for 2000 and were calculated using
SAS 9.3 andMicrosoft Excel 2010.
Differences in age of diagnosis and late-stage breast
cancer for whites compared to AIs were also analyzed.
Early and late-stage cases of breast cancer were classified as
premenopausal (age of diagnosis<50 years) and post-
menopausal (age of diagnosis50 years), and the percent-
age of AI and white women within each group was
calculated and compared. In addition, the percentage of
cases within each 5-year age group (from age 30-34 years
through80 years) for AI as compared to white women
was calculated and plotted as a line graph. Of all early-
and late-stage breast cancers, the percentage of AI and
white individuals with a corresponding late-stage cancer
was calculated. The chi-square test was used to determine
the presence of a statistically significant difference in per-
centages, and these statistics were also restricted to cases
diagnosed between 1995 and 2004. In addition, the age-
specific breast cancer incidence rates and corresponding
hazard ratios comparing AI rate to white rate were calcu-
lated for all years combined in 5-year age groups.
This study was approved by the University of Michi-
gan and MDCH Institutional Review Boards and the
Intertribal Council of Michigan and deemed no more
than minimal risk.
RESULTS
A total of 579,332 cancer cases were diagnosed in Michi-
gan between 1995 and 2004. Out of these 84.9% were
white, 12.1% black, 0.3% AI and 2.7% of another racial
group. Females comprised 51.9% and males 48.1% of all
cancer cases. The mean age at diagnosis among males was
65.9 years (standard deviation5 14.1) compared to 60.6
years (standard deviation5 18.4) for females.
In total, 1981 cancer cases were identified as AI
between 1995 and 2004 (Fig. 1). The most cases were
classified as AI based on reported race alone (508 cases,
25.6%). After IHS and tribal linkage, the number of cases
identified as AI increased by more than 100%, adding
1056 cases. Tribal link-only uncovered 299 (15.1%) cases
and IHS link-only uncovered 262 (13.2%) cases. Only
246 cases (12.4%) were identified as AI by all 3 methods.
From 1995-2004, there was an increase in all-sites
rate for AIs, from 382.4 cases per 100,000 persons (95%
CI5 313.0, 451.8) in 1995 to 405.5 cases per 100,000
persons (95%CI5 343.3, 467.6) in 2004 (Table 1). Sim-
ilar increases were observed for males and females individ-
ually (data not shown). Rates for both sexes combined
were lower for AIs than any other race. The number of all-
sites cases for all races ranged from 47,440 cases in 1995
to 54,514 in 2003 and from 140 cases in 1995 to 211
cases in 2003 for AIs.
Table 1 shows that breast cancer rates were highest
for white women and lowest for AI women. Both racial
groups experienced a peak in 2000 at 141.4 cases per
100,000 women (95% CI5 137.9, 144.8) for whites and
118.2 cases per 100,000 women (95% CI5 70.8, 165.7)
for AIs with a subsequent decline in rate (Table 1).
Among AI women there were 236 breast cancer cases seen
between 1995 and 2004 versus 71,747 among all races.
For all races, the early-stage breast cancer rates were
greater than those for late-stage breast cancers. From
1995-2004 AI women had a 60% decrease in early-stage
breast cancer rate with the lowest rate of all racial groups.
However, late-stage rates steadily increased for AI women
and, while still lower than that of other groups,
approached the rate for white women. A greater percent-
age of AIs were diagnosed with a late-stage cancer
(31.0%) as compared to white women (26.3%); however,
this result was not statistically significant (v25 2.8,
P5 .1).
The mean age at diagnosis for women with early- or
late-stage breast cancer was 55.4 years (standard
deviation5 14.3) for AI women and 61.7 years (standard
deviation5 13.9) for white women. 36.5% of breast can-
cers in AI women were diagnosed before age 50 as
Figure 1. Number and Percentage of Cases by Reported Race
and Linkage Status.
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compared to 22.2% for white women (v25 29.9,
P< .0001). A greater percentage of AI women with breast
cancer were diagnosed at younger ages than white women.
The age group with the greatest percentage of breast can-
cer cases for AI women was 60-64 years (14.1%), after
which there was a drop-off with lower percentages of
women affected at older ages. Conversely for white
women, there was a large plateau in percentage of women
from the 50-54 through the 70-74 age groups and subse-
quently a decline (Table 2). In terms of age-specific inva-
sive breast cancer rates both racial groups had the highest
rate in the 75-79 age group, but white women had greater
age-specific rates than AI women in each age group except
30-34 years. The age-specific hazard ratio (AI: white)
steadily decreased between ages groups from 30-34 to 55-
59 (from 1.1 to 0.5) before increasing slightly to 0.8 at
ages 60-64 years, and then continuing to decrease (Table
2). Comparisons of the age-specific incidence of invasive
breast cancer rates between black and AI women are
shown in the supporting information.
DISCUSSION
Because of the small number of AI individuals relative to
other racial groups, it can be difficult to generate accurate
data on cancer incidence in the AI population. Wide-
spread misclassification of this group makes assessment of
cancer burden in this population group suspect without
adjustment. As a result, cancer incidence in this popula-
tion is understudied and not well understood. Other stud-
ies have focused on comparing groupings of AIs, often by
IHS or CHSDA areas, to understand relative disease bur-
den,21-23 but these fail to take into account the heteroge-
neity of tribes in terms of culture and associated risk
factors.23 To our knowledge, this study was the first to
focus on the all-sites and breast cancer burden for AIs in
Michigan specifically after conducting IHS and tribal
linkages.
These results were similar compared to those seen in
other studies and the SEER cancer database. SEER 13
data revealed the AI/AN all-sites rate for both sexes to be
lower than that of all other racial groups with a slight
increase over time. Equivalent trends were seen in Michi-
gan, although the incidence estimates for some years were
slightly higher than those for SEER. Breast cancer rates
for AI/AN females in SEER were lower than those for
whites; however, no decrease in rate was seen in the SEER
data as compared to the slight decrease in Michigan.2
SEER is meant to give representative data based on speci-
fied catchment areas, and the SEER 13 database was
expanded to include the Alaskan Native Tumor Registry.
Therefore, trends in SEER may be skewed toward the AI/
AN populations represented.24 Similar statewide linkage
studies have also found AI all-sites and breast cancer rates
to be lower than that of all-races or NHWs, although the
degree of difference varied widely and temporal relation-
ships were not taken into account.14-16
Previously, nationwide studies have suggested that
there is a greater burden of late-stage and early-onset
breast cancer in this population as compared to whites.8,25
The results support this finding but are still inconclusive;
a variety of risk factors may contribute to these patterns,
and further research is needed on this point. A greater per-
centage of AI women were diagnosed with a late-stage
breast cancer as compared to white women, and there was
TABLE 2. Invasive Breast Cancer Age-Specific Incidence by Race and Age Group
Age Group
AI White
Hazard Ratio
(AI:White) 95% CI% of Cases
Rate (Per
100,000
Persons) 95% CI % of Cases
Rate (Per
100,000
Persons) 95% CI
30-34 4.0 32.2 (11.2, 53.2) 1.3 28.3 (26.4, 30.2) 1.1 (0.6, 2.3)
35-39 5.7 45.1 (20.6, 69.7) 3.2 61.3 (58.6, 63.9) 0.7 (0.5, 1.2)
40-44 9.7 78.2 (45.5, 110.9) 6.5 120.5 (116.8, 124.2) 0.7 (0.5, 0.9)
45-49 13.2 116.8 (75.0, 158.5) 9.6 192.6 (187.7, 197.5) 0.6 (0.5, 0.8)
50-54 12.8 143.1 (91.1, 195.2) 10.9 258.4 (252.2, 264.5) 0.6 (0.4, 0.7)
55-59 9.7 158.3 (92.2, 224.4) 11.0 322.0 (314.4, 329.6) 0.5 (0.4, 0.7)
60-64 14.1 325.2 (212.7, 437.7) 10.7 385.2 (376.0, 394.4) 0.8 (0.6, 1.2)
65-69 9.3 278.9 (159.8, 398.0) 11.1 431.3 (421.1, 441.5) 0.7 (0.5, 0.9)
70-74 8.8 331.9 (186.7, 477.1) 11.5 463.2 (452.5, 474.0) 0.7 (0.5, 1.0)
75-79 7.0 369.1 (188.6, 549.6) 10.6 485.1 (473.4, 496.8) 0.8 (0.5, 1.2)
801 5.7 278.0 (127.1, 428.9) 13.7 436.1 (426.9, 445.3) 0.6 (0.4, 1.0)
Abbreviations: AI, American Indian; CI, confidence interval.
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an increasing trend in incidence rate from 1995 through
2004 of late-stage breast cancer in AI females as compared
to decreasing rates for white females. The mean age of
breast cancer diagnosis for AIs was younger than that of
whites, a greater percentage of AIs diagnosed were under
50 years and the percentage distribution of individuals
diagnosed within each age group was shifted toward
younger age groups for AIs as compared to whites. These
results parallel trends that have been observed by tribal
clinic managers in Michigan as reported to the Intertribal
Council. However, a potential bias may exist because the
percentage of individuals within each age strata inherently
depends on the total population distribution. During the
study period, the population structure for AI females was
shifted toward younger ages as compared to whites. 62%
of all AI females ages 30 and older were in the 30-49 age
group as compared to 49% of white females. Compari-
sons based on age-specific incidence rates may therefore
be more reliable. AI women had lower age-specific rates
than white women, but the gap between the 2 rates
appears to become wider as age increases, which is also
reflected in the hazard ratio trend up to age 60. Thus, the
relative burden of invasive breast cancer for AI women
compared to white women decreases with increasing age.
This trend may be due to differential screening between
groups, although this would not affect younger women
due to screening guidelines. Because previous studies have
shown that a younger age of breast cancer diagnosis con-
fers a lower chance of survival, possibly due to later stage,
larger and higher grade cancers, these results support the
importance of improved, targeted screening practices for
specific subgroups.26,27
There were many strengths to these analyses. Cancer
registry data that had previously been linked to IHS and
tribal records was used, which is crucial in improving the
incidence estimates for the AI population. Similar to other
states, significant increases in the number of individuals
defined as AI after conducting data linkage was found.
More than 50% of all final cases identified as AI would not
have been discovered without either IHS and/or tribal link-
age. Although many states have begun to use IHS linkage
in cancer registries,14-16 Michigan used tribal linkage as a
supplement to catch those members of a tribe that may not
use IHS services.13 When studying populations with small
numbers, such as AIs, it is imperative to identify as many
cases as possible for accurate estimates. This focus onMich-
igan AIs will better uncover the true cancer burden in their
communities. Because of the diversity of individual tribes,
findings from studies based on large geographic areas are
likely an overgeneralization. With this updated racial data
these results will be applied to improve cancer treatment
and prevention programs inMichigan specifically.
These results should be interpreted with caution.
During the study years (1995-2004), AIs comprised
between 0.7% and 0.8% of the Michigan population19
and only 0.3% of all cancer cases in the state. Although
data linkage was completed prior to analysis, the racial
data is still not completely up to date. IHS linkage is run
yearly, but not all AIs in Michigan are eligible for or use
IHS services and therefore are not be captured by this
link. Only those belonging to a federally recognized tribe
are eligible, and nationwide only approximately 57% of
AIs use IHS services.28 Tribal linkage helps to fill in this
gap. At the time of the study, however, only 5 of the 12
federally recognized tribes in Michigan had participated,
missing approximately 20% of all Michigan tribal mem-
bers. Tribal linkage is unique from IHS linkage in that it
can be conducted only with permission and cooperation
of the tribe. In addition, the completeness of available
tribal enrollment information may not be complete going
back in time, making assessment of cancer incidence in
prior years difficult. This limitation became apparent after
calculating the all-sites incidence rate estimates back
through 1985 (data not shown).
An additional important limitation of our results is
that the incidence estimates may also be affected by inac-
curacies in census data, which was used as the denomina-
tor for analysis. Racial information within the census is
based on self-report. Starting in 2000, individuals could
select multiple races and were categorized separately
whereas previously only one race could be marked.29 Sim-
ilar to racial misclassification seen in cancer registries,
these categorizations may inaccurately reflect an individu-
al’s true racial identity.
In conclusion, the results of this study further our
knowledge of cancer disparities, particularly breast cancer,
that affect AI communities in Michigan. This work high-
lights the benefits of conducting regular data linkage for
cancer registries against IHS and tribal records. This in-
formation will allow local health workers in Michigan to
formulate the best treatment and prevention strategies
possible tailored to this population to ultimately lower the
cancer burden.
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